Evidence map›Paper›PMID 38472677›Full record

ArticleAnnals of surgical oncology2024

Cost-Effectiveness of Radar Localisation Versus Wire Localisation for Wide Local Excision of Non-palpable Breast Cancer.

Chu Luan Nguyen, Rebecca Cui, Michael Zhou, Fatema Ali, Neshanth Easwaralingam, Belinda Chan, Susannah Graham, Farhad Azimi, Cindy Mak, Sanjay Warrier

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Annals of surgical oncology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. OneMark™ breast localisation: integrating diagnosis and surgical guidance-a narrative review.Translational breast cancer research : a journal focusing on translational research in breast cancer · 2026
    Review
  4. SCOUTCancers · 2025
    Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Chu Luan NguyenDepartment of Breast Surgery, Chris O'Brien Lifehouse, Camperdown, NSW, Australia. chuluannguyen@gmail.com.ORCID http://orcid.org/0000-0002-4630-6182
Rebecca CuiDepartment of Breast Surgery, Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
Michael ZhouDepartment of Surgery, The University of Sydney, Camperdown, NSW, Australia.
Fatema AliDepartment of Surgery, The University of Sydney, Camperdown, NSW, Australia.
Neshanth EaswaralingamDepartment of Breast Surgery, Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
Belinda ChanDepartment of Breast Surgery, Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
Susannah GrahamDepartment of Breast Surgery, Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
Farhad AzimiDepartment of Breast Surgery, Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
Cindy MakDepartment of Breast Surgery, Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
Sanjay WarrierDepartment of Breast Surgery, Chris O'Brien Lifehouse, Camperdown, NSW, Australia.
The University of Sydney · AUChris O’Brien Lifehouse · AURoyal Prince Alfred Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWire localisation (WL) is the "gold standard" localisation technique for wide local excision (WLE) of non-palpable breast lesions but has disadvantages that have led to the development of wireless techniques. This study compared the cost-effectiveness of radar localisation (RL) to WL.

methodsThis was a single-institution study of 110 prospective patients with early-stage breast cancer undergoing WLE using RL with the SCOUT

resultsA total of 110 WLEs using RL cost a total of AUD$402,281, in addition to the device cost of AUD$77,150. The average additional cost of a surgery delay was AUD$2318. Use of RL reduced the surgery delay rate by 10% (p = 0.029), preventing 11 delays with cost savings of AUD$25,496. No differences were identified in positive margin rates (RL: 11.8% vs. WL: 17.3%, p = 0.25) or re-excision rates (RL: 14.5% vs. WL: 21.8%, p = 0.221). In total, 290 RL cases are needed to break even. The cost of WLE using RL was greater than WL by AUD$567. There was a greater clinical benefit of 1.15 quality-adjusted life-years (QALYs) and an incremental cost-utility ratio of AUD$493 per QALY favouring RL.

conclusionsRoutine use of RL was a more cost-effective intervention than WL. Close to 300 RL cases are likely needed to be performed to recover costs of the medical device. CLINICAL

trial registrationACTRN12624000068561.

Indexed as

Breast NeoplasmsCost-Benefit AnalysisAdultAgedAustraliaFemaleFollow-Up StudiesHumansMargins of ExcisionMastectomy, SegmentalMiddle AgedPrognosisProspective StudiesQuality-Adjusted Life YearsSurgery, Computer-AssistedBreast cancerCost analysisRadar localisationSAVI SCOUTWide local excisionWire localisation

Identifiers

PMID38472677
PMCPMC11076345
OpenAlexW4394760963

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.